Dr. Chuxian Zhao has nearly two decades of clinical experience in hematology and has previously served for many years in the Department of Hematology at Shanghai General Hospital, where she developed solid clinical expertise and extensive experience in managing high-complexity cases. She specializes in the standardized and individualized treatment of a wide spectrum of hematologic diseases, including acute and chronic leukemia, aplastic anemia, and myelofibrosis. Dr. Zhao has established a mature and precise clinical framework for the full-process management of HSCT. Her academic visit to Massachusetts General Hospital further broadened her international perspective and reinforced her capabilities in multidisciplinary collaboration, as well as in the advanced management of transplantation and transplant-related infections. She is highly skilled in handling complex transplant cases and is widely recognized by both patients and peers for her clinical judgment and treatment excellence.
Dr. Zhao’s academic work focuses on precision diagnosis in hematologic malignancies, optimization of transplant medicine, and innovation in therapeutic strategies. She has been actively involved in multicenter studies and major research initiatives, contributing to advances in leukemia classification, diagnostic pathway refinement, and transplantation strategy development. Her research has been published in both domestic and international peer-reviewed journals and has been presented at leading international hematology conferences, reflecting her academic depth, innovative capacity, and sustained influence in the fields of hematology and HSCT. Through her dedication to clinical translation of research findings, she continues to contribute meaningfully to improving hematologic care and advancing transplantation medicine.
